These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19550117)

  • 1. Effect of RhoA signaling transduction on expression of Ezrin in breast cancer cell lines.
    Ma L; Liu YP; Zhang XH; Xing LX; Wang JL; Geng CZ
    Ai Zheng; 2009 Feb; 28(2):108-11. PubMed ID: 19550117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of RhoA signaling activity with ezrin expression and its significance in the prognosis for breast cancer patients.
    Ma L; Liu YP; Zhang XH; Geng CZ; Li ZH
    Chin Med J (Engl); 2013 Jan; 126(2):242-7. PubMed ID: 23324271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.
    Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C
    Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phosphorylation of ezrin Tyr477 is critical in invasion of breast cancer cells stimulated by precursor of nerve growth factor].
    Li FX; Shao WF; Tang R; Yu XR; Wen QS; Yu YL; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(7):898-903. PubMed ID: 27435765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
    Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
    Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor.
    Chen Z; Fadiel A; Feng Y; Ohtani K; Rutherford T; Naftolin F
    Cancer; 2001 Dec; 92(12):3068-75. PubMed ID: 11753986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.
    Fagan-Solis KD; Schneider SS; Pentecost BT; Bentley BA; Otis CN; Gierthy JF; Arcaro KF
    J Cell Biochem; 2013 Jun; 114(6):1385-94. PubMed ID: 23255405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
    Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
    Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of PtdIns(4,5)P2 in the regulatory mechanism of small intestinal P-glycoprotein expression.
    Kobori T; Harada S; Nakamoto K; Tokuyama S
    J Pharm Sci; 2014 Feb; 103(2):743-51. PubMed ID: 24311454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion.
    Kwon A; Lee HL; Woo KM; Ryoo HM; Baek JH
    Mol Cells; 2013 Dec; 36(6):548-55. PubMed ID: 24241683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.
    Molli PR; Adam L; Kumar R
    Clin Cancer Res; 2008 Oct; 14(19):6161-70. PubMed ID: 18829495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor stimulates human trophoblast cell migration through Rho A and Rho C activation.
    Han J; Li L; Hu J; Yu L; Zheng Y; Guo J; Zheng X; Yi P; Zhou Y
    Endocrinology; 2010 Apr; 151(4):1732-42. PubMed ID: 20150581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F; Xia W; Li A; Zhao C; Sun R
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistin, a fat-derived secretory factor, promotes metastasis of MDA-MB-231 human breast cancer cells through ERM activation.
    Lee JO; Kim N; Lee HJ; Lee YW; Kim SJ; Park SH; Kim HS
    Sci Rep; 2016 Jan; 6():18923. PubMed ID: 26729407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow.
    Kosako H; Yoshida T; Matsumura F; Ishizaki T; Narumiya S; Inagaki M
    Oncogene; 2000 Dec; 19(52):6059-64. PubMed ID: 11146558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
    Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
    Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina.
    Kitaoka Y; Kitaoka Y; Kumai T; Lam TT; Kuribayashi K; Isenoumi K; Munemasa Y; Motoki M; Kobayashi S; Ueno S
    Brain Res; 2004 Aug; 1018(1):111-8. PubMed ID: 15262212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
    Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
    Weng MS; Ho CT; Ho YS; Lin JK
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.